Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2792277 | Best Practice & Research Clinical Endocrinology & Metabolism | 2006 | 14 Pages |
Abstract
Over the last 10 years, structural studies of the ligand-binding domains of nuclear hormone receptors have provided a wealth of information on the nature of ligand-binding and its role in receptor activation. This review examines the insights that studies on oestrogen receptor subtypes ERα and ERβ have provided in terms of (1) basis of receptor activation; (2) recruitment of coregulators; (3) hormone recognition; and (4) subtype-selective ligands. It also highlights the implications for the binding of endocrine disruptors.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Ashley C.W. Pike,